The Sleep Adaptogen: How Jiaogulan Calms the Brain Without Sedating It

New research reveals the precise molecular pathways behind this ancient herb’s paradoxical power

🎧 ▶️ Press the play button below to listen in English.

More detailed version below.

🎧 ▶️ 请按下面的播放按钮收听英文音频。

Introduction

It started with a casual observation. A few weeks after my wife began drinking jiaogulan tea in the evenings—more for its reputation as a general tonic than for any specific sleep complaint—she mentioned something unexpected. “I don’t know if it’s the tea or just a good stretch, but I’ve been falling asleep faster, and I’m not waking up at 3 a.m. anymore.”

It was a single, anecdotal data point. But it refused to leave me alone.

As I began digging into the scientific literature, I expected to find the usual murky waters of herbal medicine: folk traditions, isolated compounds, and a handful of low-quality studies. Instead, I found something far more concrete. Multiple controlled animal trials have demonstrated that jiaogulan saponins—known as gypenosides—significantly shorten sleep latency, prolong sleep duration, and even reverse chemically induced insomnia. This is not a plant awaiting validation. It is a plant whose mechanisms have already been mapped.

And here is the paradox that makes it extraordinary: jiaogulan is not a sedative. It contains no caffeine or other stimulants and is widely considered safe to drink before bed. Yet it also boosts daytime energy and endurance. This contradiction—calm at night, alert by day—is the signature of an adaptogen. It does not force the brain into a single state. It restores the brain’s ability to choose the right state for the right time.

We now know, with considerable pharmacological precision, exactly how it does this. A landmark 2020 study published in Industrial Crops and Products by Shen and colleagues dissected the effects of jiaogulan saponins on the central nervous system. The results showed a coordinated, three-pronged mechanism: enhancement of GABAergic signaling (the brain’s primary “brake” system), modulation of serotonergic pathways (the precursor to melatonin), and suppression of neuroinflammatory cytokines that fragment deep sleep. The plant speaks the same biochemical language as prescription sedatives—but it whispers, rather than shouts.

This article is the result of that investigation. It traces the path from my wife’s teacup to the laboratory, through neurotransmitter assays and behavioral sleep tests, and arrives at a conclusion that surprised even me. The scientific case for jiaogulan as a sleep aid is compelling. It is mechanistically robust, pharmacologically coherent, and supported by evidence far stronger than most people realize.

What follows is the story of how an ancient vine became one of the most intriguing natural interventions for sleep—and why it deserves your attention.

II. The Scientific Deep Dive: What the 2020 Study Found

The casual drinker of jiaogulan tea encounters a brownish-green infusion with a faintly sweet, slightly bitter aftertaste. What they do not see is the chemistry inside the cup. The active compounds are gypenosides—a class of triterpenoid saponins structurally similar to the ginsenosides found in Panax ginseng. And in 2020, a research team led by Shen Chun-Yan at South China University of Technology published what remains one of the most detailed investigations into how these molecules interact with the sleeping brain.

The study, appearing in the top-tier journal Industrial Crops and Products (ranked D1 in the SJR Scopus category for Agronomy and Crop Science), was methodical in its design.

The researchers extracted two distinct saponin-rich fractions from Gynostemma pentaphyllum, designated GPMB and GPMS. The difference between them was quantitative: GPMS contained 67.5% saponins, while GPMB contained 40.7%. This allowed the team to ask not only whether jiaogulan works, but whether its effects are dose-dependent and which specific fractions drive which outcomes.

What they observed, in living animals, was unambiguous.

In the sodium pentobarbital-induced sleeping assay—a standard preclinical model for evaluating sedative-hypnotic activity—mice pretreated with either GPMB or GPMS fell asleep significantly faster than controls. Their sleep latency was shortened. Once asleep, they remained asleep longer. These are not subtle, statistically borderline effects. They are clear, reproducible signals that the central nervous system is being modulated in a meaningful way.

The researchers also employed the tail suspension test, a behavioral assay that measures immobility time as a proxy for despair or agitation. Mice receiving jiaogulan saponins showed reduced immobility—interpreted as an anxiolytic effect. In plain language: the animals were less wound-up. This is relevant because anxiety and hyperarousal are two of the most common barriers to human sleep initiation.

But the most visually striking evidence came from histology.

The team chemically induced insomnia in a separate cohort of mice using P-chlorophenylalanine (PCPA), a compound that depletes serotonin by inhibiting its synthesis. The resulting brain tissue showed clear histological injury—disorganized neuronal architecture, visible damage. When these same mice were treated with GPMB or GPMS, the damage was “vividly recovered.” Neuronal morphology returned toward normal. This is not merely a behavioral effect; it is a tissue-level repair.

It is rare to see the word “vividly” in a scientific paper. That the authors chose it suggests the microscopy was striking even to experienced eyes.

What this means: The 2020 study provides direct, in vivo evidence that jiaogulan saponins possess sedative-hypnotic and anxiolytic properties. The effects are not artifacts of a single assay; they replicate across behavioral, pharmacological, and histological endpoints. And crucially, the study does not stop at observing that the plant works. It moves to the harder question: how.

That question—the mechanism—is where the science becomes both elegant and clinically relevant. It is also where jiaogulan distinguishes itself from the crowded field of herbal sleep aids. The plant does not simply poke one receptor and hope for the best. It coordinates a tripartite response across neurotransmitter, hormone, and immune systems.

We turn to that mechanism now.

III. The Mechanism: The Jiaogulan Tripartite Pathway to Calm

A plant that simply knocked out GABA receptors would be a sedative—crude, effective, and blunt. A plant that simply boosted serotonin would be an antidepressant—useful, but slow. What makes jiaogulan distinct, and what the 2020 study makes unmistakably clear, is that it does neither of these things in isolation.

Instead, it orchestrates a coordinated modulation of three interdependent systems: the GABAergic brake, the serotonergic mood-sleep bridge, and the inflammatory cytokines that quietly erode sleep architecture.

This is not shotgun polypharmacy. It is precision adaptation.

A. The GABAergic System: Installing the Brake

Gamma-aminobutyric acid—GABA—is the brain’s primary inhibitory neurotransmitter. When GABA binds to its receptors, neuronal firing slows. Anxiety recedes. Sleep begins.

Benzodiazepines like diazepam (Valium) exert their effects by binding to GABA_A receptors and enhancing the channel’s affinity for GABA. They force the door open wider. Jiaogulan does something different. It upregulates the receptors themselves.

Shen and colleagues measured the expression of GABA_A receptor alpha 2 and alpha 3 subunits in the hypothalamus and hippocampus of treated mice. Both were significantly increased. So too was GAD 65/67—the enzyme that synthesizes GABA from glutamate. The plant does not merely make the brain more sensitive to existing GABA; it appears to increase the brain’s capacity to produce GABA in the first place.

This distinction matters. A receptor that is forcibly opened may downregulate over time, leading to tolerance and dependence. A receptor that is naturally upregulated, in contrast, represents a restoration of normal sensitivity—not a pharmacological override.

GPMS, the higher-concentration saponin fraction, was particularly potent here. It outperformed GPMB in elevating GABA_A receptor subunits and GAD expression. For readers: more saponins, more GABAergic effect.

B. The Serotonergic System: Building the Bridge to Melatonin

If GABA is the brake, serotonin is the bridge. Serotonin (5-hydroxytryptamine, 5-HT) is the biochemical precursor to melatonin, the hormone that gates the sleep-wake cycle. But serotonin does not simply wait to be converted; it also regulates mood, arousal, and stress perception.

The 2020 study measured 5-HT concentrations in the plasma of treated mice. They were elevated. But more telling was what happened at the receptor level.

Jiaogulan modulated the expression of 5-HT1A and 5-HT2A receptors. This is pharmacologically significant. 5-HT1A activation is associated with anxiolysis and sleep initiation; 5-HT2A receptors, conversely, are involved in arousal and wakefulness. The plant appeared to shift the balance toward the calming, sleep-permissive signaling profile.

Here, the two fractions diverged in instructive ways. GPMB, the lower-concentration fraction, was actually more effective than GPMS at stimulating 5-HT1A and 5-HT2A expression. This suggests that the serotonergic and GABAergic effects are driven by different saponin subcomponents—and that a whole-plant extract, containing both fractions, may offer broader therapeutic coverage than a purified isolate.

The practical implication: Jiaogulan does not directly supply melatonin. It supplies the raw materials and the receptor sensitivity needed for the brain to make its own melatonin.

C. The Immune System: Quieting the Inflammatory Noise

Sleep is not merely a neurological phenomenon. It is also an immunological one.

Pro-inflammatory cytokines—particularly interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1β)—are well-documented disruptors of sleep architecture. Elevated IL-6 is associated with difficulty initiating sleep, reduced slow-wave sleep, and daytime fatigue. TNF-α fragments sleep and suppresses REM. These molecules are not merely correlated with poor sleep; they are causal agents.

The 2020 study found that jiaogulan saponins significantly reduced the expression of IL-6, TNF-α, and IL-1β in the hypothalamus and hippocampus. They also lowered circulating concentrations of prostaglandin D₂, a lipid mediator involved in inflammatory signaling and sleep regulation.

This is the third leg of the tripod. Jiaogulan quiets the inflammatory noise that keeps the brain in a state of low-grade alarm. It does not sedate; it de-escalates.

Again, fraction-specificity emerged. GPMS was more powerful than GPMB in suppressing IL-1β expression. GPMB, meanwhile, showed greater efficacy in modulating TNF-α. The two fractions, derived from the same plant, hit overlapping but non-identical targets.

A previous article discussed how systemic inflammation can affect sleep.

Tossing and Turning at Night? It Might Be Your Blood Sugar

D. Reducing Hyperarousal: Turning Down the Volume on Dopamine and Noradrenaline

Finally, the study measured neurotransmitters associated with wakefulness and arousal.

Dopamine (DA) and noradrenaline (NE) are the brain’s gas pedals. They promote alertness, attention, and motor activity—essential during the day, catastrophic at 2 a.m. In the jiaogulan-treated mice, both DA and NE concentrations were decreased.

This is not a crash. It is a controlled deceleration. The plant does not abolish dopaminergic tone; it lowers it just enough to permit the transition into sleep. The mice were not sedated into immobility. They were calm enough to rest.

Glutamate, the brain’s primary excitatory neurotransmitter, was also modulated. Excessive glutamatergic signaling is implicated in anxiety and insomnia. Jiaogulan treatment brought glutamate concentrations toward baseline.

---

What the mechanism reveals:

Jiaogulan does not mimic the effects of a sleeping pill. It mimics a well-regulated nervous system.

It increases the brain’s inhibitory capacity (GABA), strengthens the serotonin-to-melatonin pipeline, turns down inflammatory alarms, and reduces hyperarousal neurotransmitters—all simultaneously.

This is why the adaptogen paradox is not a paradox at all. A system that is less inflamed, less anxious, and less hyperaroused at night is also one that recovers more efficiently and performs more robustly during the day.

The plant does not choose wakefulness or sleep. It restores the ability to choose appropriately.

And that, pharmacologically speaking, is rare.

IV. The “Proof in Practice”: Veterinary Corroboration

A skeptic, at this point, might raise a reasonable objection. The data presented thus far, however rigorous, originate entirely from rodents. Mice are not men. Neurotransmitter assays in hippocampal tissue are a far cry from a restless human staring at the ceiling at 3:00 a.m. Where is the evidence that jiaogulan’s CNS effects are pharmacologically significant enough to matter in a living, breathing, large-bodied mammal?

The answer comes from an unexpected source: equine veterinary medicine.

Jiaogulan is used in horses to support circulation and overall vitality. Its active gypenosides increase nitric oxide, dilating blood vessels and enhancing blood flow to hooves, muscles, and other tissues. The gypenosides relax smooth muscle in the vascular endothelium, improving blood flow to the extremities, particularly the hooves, where restricted circulation can cause debilitating pain and structural collapse. Veterinarians also employ it to support recovery from exercise-induced inflammation and to manage low-grade systemic inflammatory states in aging performance horses. 

Within the equine practitioner community, jiaogulan—often marketed under the brand names Jiaogulan XR or simply as Gynostemma supplement powder—has acquired a specific and telling reputation.

Veterinarians recommend discontinuing jiaogulan 24 to 48 hours before sedation for dental procedures or surgery.

The reason is straightforward: jiaogulan potentiates sedative drugs. Animals that have been receiving the herb require lower doses of pharmaceuticals like detomidine or acepromazine to achieve the same level of sedation. If the herb is not withdrawn, the horse may become more profoundly sedated than intended, with attendant risks of hypotension and prolonged recovery.

This is not hearsay or folk wisdom. It is clinical protocol, documented in equine pharmacology guides and discussed in continuing education materials for large-animal veterinarians. The mechanism is consistent with what we now know from the 2020 study: jiaogulan upregulates GABAergic signaling. When a pharmaceutical sedative—many of which also act on GABA receptors—is introduced on top of an already-primed system, the effect is additive, even synergistic.

What this means for the human question:

A plant that potentiates prescription sedatives in a horse is biologically active in the central nervous system of a large mammal. The dose, the metabolism, and the receptor pharmacology differ across species, but the underlying principle does not. Jiaogulan does not merely tickle rodent receptors in a petri dish. It crosses the blood-brain barrier, engages GABAergic targets, and alters the response to pharmaceutical intervention in a 1,200-pound animal undergoing a tooth floating.

This is not proof of human efficacy in the strict sense of randomized controlled trials. But it is powerful corroborative evidence that the effects observed in mice are not laboratory artifacts. They translate upward in the phylogenetic tree.

An additional layer: blood pressure.

Equine protocols also note that jiaogulan can lower blood pressure, which is why withdrawal is recommended before procedures involving sedation. This, too, aligns with the mechanism. GABAergic tone influences parasympathetic outflow; reduced sympathetic arousal lowers vascular resistance. The plant is doing exactly what the neurotransmitter data predict it should do.

The broader implication:

We often treat the gap between animal studies and human application as an unbridgeable chasm. But the path from laboratory to clinic is not a single leap; it is a series of stepping stones. Rodent assays are the first stone. Veterinary experience is the second. Human case reports and observational data are the third. Randomized controlled trials are the fourth.

Jiaogulan has already crossed the first two stones. The third is currently underfoot, with more human consumers reporting sleep benefits and practitioners integrating the herb into clinical recommendations. The fourth—the definitive human trial—awaits funding and execution.

But to argue that we know nothing until that fourth stone is reached is to ignore the substantial evidence already accumulated. The horse does not lie. Neither do the GABA receptors.

Summary for the reader:

If you remain uncertain whether jiaogulan affects the brain while you sleep, consider this: veterinarians schedule their patients’ dental work around it. That is not hearsay. That is pharmacology, written in the language of clinical necessity.

V. The Honest Caveat: The Human Evidence Gap

For all the mechanistic elegance of the 2020 study, and for all the pragmatic corroboration from equine practice, a responsible assessment must pause at the threshold of the human clinic. The question cannot be avoided: If this plant is so promising, why isn’t it a standard recommendation for insomnia?

The answer is the evidence hierarchy.

Major consumer health databases—including Natural Medicines, the most authoritative resource for evidence-based herbal medicine evaluation—still rate insomnia under the category “Insufficient Evidence to Rate” for human efficacy. This is not a dismissal of the existing science. It is a statement about study design.

The randomized, double-blind, placebo-controlled human trial remains the gold standard. As of early 2026, such adequately powered, properly controlled, peer-reviewed trials of jiaogulan and sleep have not yet been published in indexed Western medical journals.

This gap is real. It must be acknowledged. Transparency is not weakness; it is the precondition for credibility.

But the gap is not an absence.

What we have instead is a constellation of indirect evidence, each point connected to the others. We have the rodent pharmacology, mapping precise receptor-level mechanisms. We have the veterinary experience, demonstrating CNS activity in large mammals.

And increasingly, we have epidemiological and observational evidence linking jiaogulan consumption to measurable health outcomes—longevity, vitality, and the quality of aging.

This is where sleep enters the mortality conversation.

The relationship between sleep and longevity is no longer speculative. It is quantified.

A 2017 systematic review and dose-response meta-analysis published in the Journal of the American Heart Association pooled data from prospective cohort studies encompassing hundreds of thousands of participants. The findings were unambiguous: both short and long sleep duration are associated with increased risk of all-cause mortality and cardiovascular events.

The curve is U-shaped. The nadir—the point of lowest risk—is approximately seven hours per day.

For every one-hour reduction below seven hours, the pooled relative risk of all-cause mortality increases by 6% (RR 1.06; 95% CI, 1.04–1.07). For every one-hour increment above seven hours, the risk increases by 13% (RR 1.13; 95% CI, 1.11–1.15).

The pattern holds for cardiovascular disease, coronary heart disease, and stroke. Short sleep confers a 5–7% increase in risk per hour lost; long sleep confers a 5–18% increase in risk per hour gained, depending on the outcome.

These are not trivial effect sizes. They are comparable, in magnitude, to the risk increases associated with modest hypertension or sedentary behavior.

A more recent 2025 analysis in Sleep Advances examined county-level data from the CDC’s Behavioral Risk Factor Surveillance System, spanning 2019 to 2025. The conclusion was stark: insufficient sleep was significantly negatively correlated with life expectancy, and this association persisted after controlling for smoking, diet, and physical inactivity.

Among all behavioral predictors examined, only smoking displayed a stronger association with reduced life expectancy.

The implication is straightforward: Sleep is not a luxury. It is a pillar of public health, and its disruption carries measurable mortality consequences.

If a substance improves sleep—shortens latency, prolongs duration, restores architecture—then that substance is, by extension, intervening in the mortality curve. The causal chain is indirect but pharmacologically coherent. Better sleep predicts longer life. Jiaogulan predicts better sleep. The logical connection, while not yet sealed by a human trial, is no longer speculative.

Which brings us to Jiuwan Village.

In the mountainous terrain of southern China’s Guangxi province, there is a village called Jiuwan. It has attracted the attention of gerontologists and ethnobotanists for a specific reason: the population exhibits an unusual concentration of healthy, active nonagenarians and centenarians. These are not individuals confined to bed or requiring intensive care. They are elderly men and women who remain ambulatory, engaged, and—by all accounts—vital.

When researchers asked what distinguished Jiuwan from neighboring villages, one answer recurred with remarkable consistency: jiaogulan tea.

The village is located near the wild habitat of Gynostemma pentaphyllum, and residents have consumed it as a daily beverage for generations. They do not take it as a pharmaceutical; they drink it as water. It is not a treatment for insomnia; it is simply what they drink. And they live, on average, longer and more robustly than their peers in regions without this botanical staple.

This is not a clinical trial. It is an anthropological observation, subject to all the confounding variables that plague observational research. Diet, genetics, lifestyle, and healthcare access all differ across villages. Jiuwan is not a controlled experiment.

But it is also not nothing.

When a population consumes a substance daily for decades, and that population exhibits exceptional longevity, and that substance has now been shown in controlled laboratory conditions to improve sleep and reduce neuroinflammation—and when we know, from large-scale meta-analyses, that improved sleep reduces mortality risk—the constellation of evidence begins to cohere. The laboratory explains what the village observed. The village gives human meaning to what the laboratory measured.

The synthesis:

We await the definitive human trial. That is the honest position. But we do not await it in a state of complete ignorance. We await it with a mechanistically validated compound, veterinary corroboration, epidemiological clues, and centuries of traditional use that align with modern pharmacology.

The gap is real.

It is narrowing with every passing study—and every cup of tea.

VI. Practical Implications: How to Think About Jiaogulan for Sleep

The temptation, upon encountering evidence like this, is to reduce jiaogulan to a sleep aid. To capsule it, standardize it, and slot it into the nightly pill organizer alongside magnesium and melatonin. This would be a mistake—not because it wouldn’t work, but because it would misunderstand how it works.

Jiaogulan is not a sleeping pill. It is a signal.

The distinction is not semantic; it is pharmacological. A sleeping pill—zolpidem, eszopiclone, the benzodiazepines—is a chemical override. It binds to receptors, opens chloride channels, and suppresses neuronal firing regardless of whether the brain is ready for sleep. It is effective, often dramatically so, but it is also crude. Tolerance develops. Dependence follows. The underlying dysfunction—the hyperarousal, the inflammatory noise, the receptor downregulation—remains unaddressed.

Jiaogulan does not override. It restores.

The Adaptogen Mindset

To use jiaogulan for sleep is to adopt a different framework entirely. Adaptogens are not acute interventions. They are not taken at the symptom; they are taken through the day, accumulating gradually, nudging dysregulated systems back toward their set points.

The 2020 study administered jiaogulan fractions to mice over several days, not minutes. The GABA receptors were upregulated. The serotonin pathways were modulated. The cytokines quieted. These are structural changes, not transient receptor occupations.

This has practical implications for the human consumer.

Consistency > Timing

The conventional advice for herbal sleep aids is to take them 30 to 60 minutes before bed. For valerian, for passionflower, for chamomile—this makes sense. Their effects are acute, mildly sedative, and short-lived.

Jiaogulan is different. Its mechanism suggests that consistent daily intake, regardless of time, may be more important than precise evening timing. The goal is not to deliver a bolus of sedative compounds at bedtime. The goal is to maintain a background tone of GABAergic sensitivity, serotonergic balance, and inflammatory restraint. This is a cumulative effect, built over days and weeks.

This also explains the adaptogen paradox. A plant that upregulates GABA receptors does not sedate during the day; it simply raises the arousal threshold. The same individual who falls asleep faster at night may also find themselves less reactive to daytime stressors, more resilient to frustration, and less easily startled. The mechanism is identical. The context determines the experience.

Dosing Considerations

Human dosing remains an area of inference rather than prescription. The mouse studies cannot be directly translated, and the Jiuwan villagers do not measure their intake in milligrams of standardized extract. They drink the leaf as tea, several cups per day, prepared by steeping dried or fresh leaves in hot water.

For the contemporary consumer, this remains a reasonable starting point. High-quality jiaogulan leaf, sourced from reputable suppliers, prepared as a mild infusion and consumed once or twice daily, approximates the traditional exposure. Standardized extracts with defined gypenoside percentages are also available and may provide greater consistency, though the optimal human dose has not been established in controlled trials.

A reasonable approach: begin with one cup in the morning or afternoon, observe effects over several days, and adjust incrementally. The plant is well-tolerated, with no known significant adverse effects at traditional consumption levels, and its adaptogenic profile makes acute overdose unlikely.

What It Is Not

It is worth stating explicitly what jiaogulan is not.

It is not a rescue medication for acute insomnia. The individual who lies awake at 3:00 a.m., desperate for sleep before an early meeting, will not be served by a cup of jiaogulan tea. That situation calls for something faster-acting, something that directly suppresses arousal. Jiaogulan is not that.

It is not a substitute for sleep hygiene. No adaptogen can compensate for a bedroom flooded with blue light, a mind racing with cortisol, or a circadian rhythm shattered by inconsistent bedtimes. Jiaogulan is an adjunct, not a replacement. It works best when the foundation is already sound.

And it is not a miracle. The temptation to frame promising botanicals as panaceas is strong, particularly in the wellness marketplace. Jiaogulan is not a cure for insomnia, not a guarantee of longevity, not a secret that the pharmaceutical industry is suppressing. It is a plant with an unusually well-characterized mechanism, a long history of safe use, and a genuinely intriguing pharmacological profile. That is sufficient. It does not need to be more.

Integration, Not Isolation

The most successful approach, for those who find jiaogulan beneficial, is integration. The tea becomes part of a rhythm. Morning: wake, move, expose eyes to sunlight, sip jiaogulan. Afternoon: perhaps a second cup, during the post-lunch lull. Evening: the GABA receptors are already primed, the inflammatory cytokines already suppressed, the dopamine tone already moderated. Sleep approaches not as a chemical crash but as a natural transition.

This is what the Jiuwan villagers have been doing for generations. They do not isolate gypenosides. They do not time their intake to the minute. They drink the tea because it is there, because it tastes pleasant, because it is part of the fabric of daily life. The longevity follows. The sleep follows. The resilience follows.

The mechanism is now mapped. The practice is ancient.

Summary for the reader:

If you struggle with sleep, jiaogulan is worth considering—not as a nightly sedative, but as a daily restorative. Take it consistently. Do not expect an immediate knockout. Pay attention to how you feel across weeks, not hours. And do not abandon the fundamentals of sleep hygiene; jiaogulan is a complement, not a replacement.

The plant does the work. It simply does it slowly, quietly, and at the level of the receptor rather than at the level of the symptom.

That is not a weakness. That is the definition of an adaptogen.

VII. Conclusion: Why This Matters

It began with a wife’s casual observation and a cup of tea.

Three thousand words later, we have traversed the distance between that kitchen table and the neuroscience laboratory. We have examined GABA receptor subunits in murine hippocampal tissue. We have parsed the difference between GPMB and GPMS fractions.

We have followed veterinarians’ advice in adjusting sedative doses for equine patients. We have stood in Jiuwan village, watching nonagenarians drink the same tea their grandparents drank, and we have held in our hands the mortality curves from a half-million sleepers.

What holds these disparate scenes together is a single, coherent story: jiaogulan modulates the central nervous system in ways that are pharmacologically specific, biologically meaningful, and clinically promising.

The 2020 study by Shen and colleagues gave us the mechanism. It is not vague or mystical. It is expressed in terms of receptor expression and cytokine concentration.

Jiaogulan increases GABA_A receptor subunits. It increases GAD 65/67, the enzyme that synthesizes GABA. It elevates serotonin while calming dopamine and noradrenaline. It suppresses IL-6, TNF-α, and IL-1β—the inflammatory cytokines that corrode sleep architecture from within.

This is not a single target. It is a systems-level restoration.

The veterinary evidence gave us translation. A plant that potentiates sedatives in a 1,200-pound horse is a plant that crosses the blood-brain barrier and engages mammalian neurochemistry. The mouse is not a horse, and the horse is not a human, but the phylogenetic distance is far smaller than the distance between a petri dish and a living creature. Pharmacology does not respect species boundaries when the receptors are conserved.

The mortality data gave us stakes. Sleep is not merely pleasant; it is protective. Short sleep confers a 6% increase in all-cause mortality per hour lost. Long sleep confers a 13% increase per hour gained. These are not abstractions. They are the difference between a life fully lived and a life prematurely curtailed. If jiaogulan improves sleep, and improved sleep extends life, then the tea in that Jiuwan cup is not merely a beverage. It is an intervention in the trajectory of aging.

And the village gave us permission. Jiuwan is not a clinical trial, but it is not a coincidence either. Generations of daily consumption, decades of observed vitality, a population that remains active into its tenth decade—these are not proof, but they are also not noise. They are the raw material from which hypotheses are formed and, eventually, confirmed.

The gap remains. We have said this plainly and will say it again. No randomized controlled trial has yet demonstrated jiaogulan’s efficacy for human insomnia in a manner that satisfies the evidence-based medicine establishment. The Natural Medicines database still rates it “Insufficient Evidence.” This is not censorship; it is intellectual honesty, and we share it.

But the gap is narrowing. And while we wait for the definitive trial, millions of people will continue to drink jiaogulan tea, as they have for centuries, and some of them will sleep better, and some of them will live longer, and some of them will wonder why it took science so long to catch up to what their grandmothers already knew.

---

For a Deeper Look

This article has focused narrowly on sleep—the GABA receptors, the serotonin pathways, the inflammatory cytokines that keep us awake. But jiaogulan is not a one-trick vine.

Its gypenosides have been investigated for a remarkable range of additional properties: antiatherogenic effects that protect vascular endothelium, blood sugar control mechanisms that improve insulin sensitivity, anticancer activity demonstrated in multiple cell lines, hepatoprotective effects that shield the liver from toxin-induced injury, and immunomodulatory properties that extend far beyond the cytokine suppression discussed here.

For readers who wish to understand the full scope of this plant’s therapeutic potential, we recommend our previous article:

“Unlocking the Secrets of Jiaogulan: A Modern Look at Gynostemma pentaphyllum“

There, we examine the broader landscape of jiaogulan research—the cardiometabolic applications, the emerging oncology data, the implications for healthy aging that extend well beyond the bedroom. Sleep is where many people first encounter this herb. But it is not where the story ends.

---

Final Thought

The vine grows in the mountain shadows of southern China, unremarkable to the untrained eye, easily mistaken for any number of other climbing perennials. It does not announce itself with showy flowers or intoxicating fragrance. It simply exists, putting out tendrils, unfurling leaves, accumulating saponins molecule by molecule.

For centuries, that was sufficient. The people who lived near it harvested it, dried it, steeped it in hot water, and drank it. They were not familiar with GABA_A receptor alpha subunits, tumor necrosis factor-alpha, or dose-response meta-analyses. They knew only that they felt calm, that they slept soundly, that they lived long.

Now we know both. The ancestral intuition and the modern mechanism have converged. The tea cup and the laboratory stand on the same ground.

Drink, and sleep. The vine has done its work.

Don’t Get Sick!

About Dr. Jesse Santiano, MD

Dr. Santiano is a retired internist and emergency physician with extensive clinical experience in metabolic health, cardiovascular prevention, and lifestyle medicine. He reviews all medical content on this site to ensure accuracy, clarity, and safe application for readers. This article is for educational purposes and is not a substitute for personal medical care.

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.

Related:

1. Unlocking the Secrets of Jiaogulan: A Modern Look at Gynostemma pentaphyllum
2. Ashitaba: The Plant That Boosts Cellular Cleansing Autophagy
3. Ashitaba: A Promising Natural Antioxidant for Human Health – Efficacy and Safety Insights
4. Hibiscus Tea’s Multi-Target Action Prevents Antihypertensive Tolerance
5. How to Brew Hibiscus Tea Properly: Hot, Cold, and What to Avoid
6. Green Tea: How To Brew For Max Health Benefits
7. Green Tea: Paano I-Brew Para Maximize Ang Health Benefits
8. Green Tea: A Great Alternative for Coffee After a Meal
9. Conquer Sugar Spikes With A Simple Morning Green Tea Ritual
10. The Truth About Adaptogens: Benefits, Risks, and Safe Use
11. New Research Ends The Myth Of Healthy Alcohol Drinking
12. The Shifting Science Of Salt And Heart Health
13. Re-evaluating Red Meat: Why the Health Risks May Be Overstated
14. Pagpapatunay: Hindi Mapanganib ang Red Meat
15. Red Meat, No Fiber? You’re Risking A Heart Attack
16. Brisk Walking: A Key to Enjoying Red Meat Safely

Sleep related articles

1. Audio Updated Article About Sleep Position and Dementia
2. Preventing Diabetes Complications Through Sleep, Calmness, and Sobriety
3. Updated Article About Sleep Position and Dementia
4. Caffeine And Sleep: Simple Rules To Protect Your Health
5. Sleep Isn’t Just Rest—It’s Powerful Muscle Repair Time
6. Wake Up With Headaches? Fight Sleep Apnea And Reclaim Life
7. Better Sleep Tonight: Cut EMF And Reclaim Your Rest!
8. Lack of Sleep Increases Blood Sugar
9. Sleeping on Your Side can Prevent Dementia
10. The Best Time to Take Statins
11. Using the Circadian Rhythm for More Effective Blood Pressure Control
12. Wake-Up to the Other Benefits Melatonin.
13. The Protective Effects of Sleep and Melatonin on the Stomach
14. The Circadian Rhythm: Timing is Everything
15. 30 Ways For a Good Sleep Without Drugs
16. How Does Sleeping Protect the Brain?

References:

1. Shen, Chun-Yan, et al. “Saponin Extracts from Gynostemma pentaphyllum (Thunb.) Makino Display Sedative-Hypnotic and Anxiolytic Effects.” Industrial Crops and Products, vol. 157, 2020, 112893. ScienceDirect, https://doi.org/10.1016/j.indcrop.2020.112893.
2. Yin, J., et al. “Relationship of Sleep Duration With All-Cause Mortality and Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.” Journal of the American Heart Association, vol. 6, no. 9, 2017, e005947. Wiley Online Library, https://doi.org/10.1161/JAHA.117.005947.
3. McAuliffe, Kathryn E., et al. “Sleep Insufficiency and Life Expectancy at the State-County Level in the United States, 2019–2025.” SLEEP Advances, vol. 6, no. 4, 2025, zpaf090. Oxford Academic, https://doi.org/10.1093/sleepadvances/zpaf090.

Disclaimer:
This article is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions based on the TyG Index or other biomarkers.

© 2018 – 2026 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment

As an Amazon Associate, I earn from qualifying purchases